Abstract The aim of this research was to synthesize and chemically characterize a cancer-specific 177 Lu-Aunanoradiopharmaceutical based on gold nanoparticles (NPs), the nuclear localization sequence (NLS)-Arg-GlyAsp peptide and an aptamer (HS-pentyl-pegaptanib) to target both the a(v)b(3) integrin and the vascular endothelial growth factor (VEGF) overexpressed in the tumor neovasculature, as well as to evaluate by the tube formation assay, the nanosystem capability to inhibit angiogenesis.
Introduction
177 Lu-nanoradiopharmaceuticals based on gold nanoparticles (NPs) are in the spotlight of theranostic innovation. Due to their optical properties, nontoxic nature, relatively simple preparation and functionalization, NPs have been successfully labeled with 177 Lu (therapeutic b À max emission of 0.497 MeV and c radiation of 0.208 MeV for diagnostic imaging) and covalently bound to molecules with targetspecific recognition to obtain nanosystems with properties suitable for optical and nuclear imaging, plasmonic-photothermal therapy and targeted radiotherapy on a single platform [1] [2] [3] .
Solid tumors require the formation of new blood vessels (angiogenesis) for growth, and many new cancer therapies are directed against the tumor vasculature [4, 5] . Multiple angiogenesis inhibitors have been therapeutically validated in preclinical and clinical trials [6] .
The a(v)b(3) integrin is a specific marker of the neovasculature, which is overexpressed in the tumor vessels during angiogenesis. The Arg-Gly-Asp (RGD) peptide motifs have been identified as high-affinity a(v)b(3) selective ligands and therefore as antiangiogenic agents [7] . Furthermore, RGD conjugated to radiolabeled peptides with a nuclear localization peptide sequence (NLS) promote the radionuclide internalization in cancer cells overexpressing a(v)b(3) integrins, increasing the effectiveness of targeted radiotherapy [8, 9] .
Aptamers are single-stranded deoxyribonucleic acid or ribonucleic acid oligonucleotides, which can bind their target with high selectivity and affinity [10] . Pegaptanib is an aptamer that inhibits angiogenesis by targeting the vascular endothelial growth factor (VEGF) pathway [11] . One of the most widely used in vitro assays to model the reorganization stage of angiogenesis is the tube formation assay. This assay measures the ability of endothelial cells to form capillary structures (tubes). The study focuses on how specific signaling molecules are involved in the threedimensional formation of vascular networks. Compounds which inhibit the formation of tubes could be useful as specific antiangiogenic agents [12] .
The use of heterobivalent molecules interacting concomitantly with different receptors in tumor cells is an approach for drug enhancement for specific and sensitive tumor imaging [13] [14] [15] .
The aim of this study was to synthesize and chemically characterize a cancer-specific 177 Lu-Au-nanoradiopharmaceutical based on NPs, NLS-RGD and aptamer able to target both the a(v)b(3) integrin and the VEGF, as well as evaluate by the tube formation assay, the nanosystem capability to inhibit angiogenesis.
Experimental Synthesis of the NLS-RGD peptide
The synthesis procedure is described in detail in the Supplementary information section. Briefly, the cyclo(ArgGly-Asp-DTyr-Lys)-3-maleimidepropionylamide (c(RGDyK)-3MP) and NH 2 -Gly 
Synthesis of the aptamer-SH (pegaptanib derivative)
The aptamer analogue to pegaptanib was designed to interact covalently with gold atoms on the nanoparticle surface by adding a HS-pentyl (-SH terminal group) and it was synthesized with support of the Iba Solutions Company (Germany). The sequence of the RNA aptamer is as follows: The 1,4,7,10-tetraazacyclododecane-N,N 0 ,N 00 ,N 000 -tetraacetic acid-Gly-Gly-Cys (DOTA-GGC) peptide to be used as chelator for Lu-177 (DOTA), was synthesized according to the method described by Luna-Gutiérrez et al. [17] . The detail methods to prepare 177 Lu-DOTA-GGC-NP and to evaluate its radiochemical purity have been shown elsewhere [17, 19] . (Fig. 1 ). For chemical characterization and comparative purposes, the radioactive and non-radioactive systems of DOTA-GGC-NP, DOTA-GGC-NP-NLS-RGD, DOTA-GG C-NP-Aptamer and DOTA-GGC-NP-NLS-RGD-Aptamer were also prepared using the same procedure.
Chemical characterization
The DOTA-GGC-NP-NLS-RGD-Aptamer was characterized in size and shape by transmission electron microscopy (JEOL JEM2010 HT microscope operated at 200 kV). The hydrodynamic diameter and Zeta potential were obtained by dynamic light scattering (DLS) (Nanotrac Wave, Model MN401, Microtract, FL, USA). The IR spectra were acquired on a PerkinElmer System 2000 spectrometer with an ATR platform (Pike Technologies ATR-FTIR) from 4400 to 570 cm -1 and 700 to 30 cm -1 . The nanoconjugate was measured by UV-Vis spectroscopy, monitoring the shift in the surface plasmon band with a Perkin-Elmer Lambda-Bio spectrometer. Raman spectra were acquired on a MicroRaman (JOBIN-Yvon-Horiba, LABRAM-HR800) spectrometer with optical microscope (OLYMPUS BX 41) and He-Ne Laser (632.8 nm) as excitation source.
Detail methods to evaluate the radiochemical purity by size-exclusion chromatography and ultrafiltration have been shown elsewhere [17, 19] .
Biochemical characterization

Cell cultures
The permanent human umbilical vein cell line (EA.hy926) was purchased from Gibco-Life Technologies (Carlsbad, CA, USA) and cultured (37°C, 5% CO 2 ) in F12 medium 200 (Gibco-Life Technologies). The C6 rat glioma cell line were obtained from American Type Culture Collection (Atlanta, GA, USA) and cultured (37°C, 5% CO 2 ) in Roswell Park Memorial Institute Medium (Sigma-Aldrich Co.). In both cases fetal bovine serum (10%), penicillin (100 U/mL) and streptomycin (100 lg/mL) were used.
Human serum stability
Radiolabeled NP ( 177 Lu-NP-NLS-RGD-Aptamer, 200 lL) were diluted in fresh human serum and incubated at 37°C. The stability was determined by UV-Vis analysis to monitor the NP surface plasmon at 60 min and 24 h after dilution. Radiochemical stability was determined by taking samples at 60 min and 24 h for ultrafiltration and sizeexclusion evaluation (PD-10 column) as reported elsewhere [17, 19] .
In vitro affinity
The method to evaluate the 177 Lu-NP-NLS-RGD-Aptamer affinity to a(v)b(3) integrins was carried out using the by a solid-phase binding assay as previously reported [17] . The IC 50 value of the 177 Lu-NP-NLS-RGD-Aptamer peptide was determined by nonlinear regression analysis (n = 5) [17] .
In vitro angiogenesis assay
An endothelial cell tube formation assay was performed using the ECMatrixTM kit (BD Biosciences, Bedford, MA, USA). Briefly, EA.hy926 cells (10,000 cells) were seeded onto polymerized ECMatrix and incubated at 37°C, 5% CO 2 . Cells were cultured with (CTL?) or without (CTL-) endothelial growth factor (ECGF, Sigma, Aldrich, USA, 20 lg/mL) in fetal bovine serum (FBS) and treated with DOTA-GGC-NP (10 lL, 1 9 10 9 nanoparticles), DOTA-GGC-NP-NLS-RGD (10 lL, 1 9 10 7 nanoparticles), DOTA-GGC-NP-Aptamer (10 lL, 1 9 10 7 nanoparticles) and DOTA-GGC-NP-NLS-RGD-Aptamer (10 lL, 1 9 10 7 nanoparticles). After 18 h, tube formation was analyzed under an inverted light microscope (Eclipse TE300; Nikon, Tokyo, Japan) at 409 magnification. The semi-quantitative measurement of the angiogenic potential was calculated by direct visual analysis of at least six microscopic fields for each experimental condition allowed the assignation of a numerical value to angiogenic potential that reflects the degree of remodeling by using the formula proposed by Aranda and Owen [18] . This also allowed the establishment of statistical differences in angiogenic potential between two conditions or compounds. 177 Lu-NP-NLS-RGD-Aptamer, in triplicate at 37°C for 2 h. The detailed method has been shown elsewhere [16, 17] . Differences between the in vitro cell data of 177 Lu-NP-NLS-RGD-Aptamer and each treatment were evaluated with Student's t test (grouped analysis, significance was defined as p \ 0.05). Results and discussion TEM images, hydrodynamic particle size and Z potential
Fluorescence microscopy images
Images of DOTA-GGC-NP-NLS-RGD-Aptamer (NPnanosytem) are shown in Fig. 2 . The a ''halo'' around the NPs was observed as consequence of the poor interaction of the electron beam with the NLS-RGD and aptamer molecules (low electron density). The average particle hydrodynamic diameter of the NP-nanosystem determined by DLS was 29.99 ± 1.90 nm, which was higher than that of NP (24.70 ± 0.07 nm). The increase in the diameter also indicated the conjugation of the aptamer and NLS-RGD to the NP surface (Fig. 2) [19] . The Z potential for the NP and NP-nanosystem was -59 ± 2.7 mV and -74 ± 4.8 mV respectively, showing an increase in the colloidal stability.
Infrared and Raman spectroscopy
The MIR spectrum of the NP-nanosystem is given in Fig. 3 . The spectrum is highly structured with fine bands not observed in the spectra of aptamer, NLS-RGD, DOTA-GGC nor the gold nanoparticles prior to their interaction (Fig. 3) . Of interest are the multiple bands observed in the NP-nanosystem spectrum in the region from 2350 to 1700 cm -1 assigned to -CH 2 NH 3 ? , R2-NH 2 ? , R3-NH ? , R-C=NH ? , protonated amidines (R2-N-C=N(-N)-R2) from the arginine, guanine and adenine, as well as vibrations in the regions of amides I, II and III, [20] . The bands up to 3500 cm -1 are assigned to the unassociated -OH from the tyrosine and asparagine of the NLS-RGD and the carboxylic acid from DOTA-GGC (Fig. 3) . The asymmetric vibrations (1234 cm -1 ) in the phosphates -O-P(O)-O-bridged to the terminal pentyl mercaptan [(CH 2 ) 5 -SH] and to the riboside (both through -CH 2 -) observed in the aptamer spectrum disappear in the NP-nanosystem spectrum, which indicate that the aptamer is bonded to NP through the HS-pentyl moiety. In Raman spectra, the bands with good intensity confirmed the assignations in MIR. A detail analysis of the Raman, MIR and FIR spectra as evidence of the NP functionalization with the aptamer and the NLS-RGD peptide are included in the Supplementary information section. 
UV-Vis spectroscopy
The NP spectrum showed a characteristic surface plasmon resonance at 519.2 nm. A red-shift to 519.5, 519.8, 521.3 and 522.3 nm was observed in the DOTA-NP, DOTA-GGC-NP-Aptamer, DOTA-GGC-NP-NLS-RGD, DOTA-GGC-NP-NLS-RGD-Aptamer spectra, respectively (Fig. 4) . A decrease can be noticed in the intensity of the surface plasmon resonance peak of the NP conjugates due to changes in the refraction index and dielectric medium because of the interaction between the GGC, NLS-RGD and the NP surface [21] .
Radiochemical purity
Radiochemical purity of the 177 Lu-NP-NLS-RGD-Aptamer nanoradiopharmaceutical determined by ultracentrifugation and PD10 size-exclusion chromatography was 99 ± 1%.
Human serum stability
177 Lu-NP-NLS-RGD-Aptamer was stable in human serum for 24 h, since at this time the radiochemical purity continues as high as 99 ± 1%. The 522.3 nm surface plasmon resonance characteristic of NP, remained stable but slightly shifted to shorter energy (521.9 nm) as consequence of the protein interactions [16] .
Solid-phase a(v)b(3) binding assay: in vitro affinity The in vitro competitive binding assay of the colloidal system 177 Lu-NP-NLS-RGD-Aptamer to determine the a(v)b(3) affinity showed that the concentration of the RGD peptide to displace 50% of the 177 Lu-NP-NLS-RGD-Aptamer from the receptor was 4.41 ± 0.4 nM (IC 50 ) (Fig. 5) . The 177 Lu-NP-NLS-RGD-Aptamer affinity is congruent with similar affinity results reported for colloidal systems based on NP-RGD and radiolabeled with 177 Lu [17] .
Endothelial cell tube formation assay
As shown in Fig. 6 , cells cultured in Matrigel with proangiogenic factors (FBS and ECGF) efficiently induced flattening and cell migration (positive control, Fig. 6a ), where cells reorganized and formed tubes and complexmulticellular polygonal structures, which are from two to three cells thick. Cells over Matrigel without any proangiogenic factors (negative control, Fig. 6d ) remained adhered to the matrix and maintained a rounded shape.
Each of the nanosystem components [DOTA-GGC-NP (Fig. 6b) ; DOTA-GGC-NPs-NLS-RGD (Fig. 6c) ; or DOTA-GGC-NP-Aptamer (Fig. 6e) ] regulated in a negative manner and with different intensity the key steps of the angiogenic process (adhesion, protrusion, cell-cell contact or cell migration). EA.hy926 cells cultured over Matrigel and stimulated with FBS and ECGF were quickly adhered and formed projections increasing cell-cell contact to migrate until forming polygonal structures that gain complexity over time (Fig. 6a) .
The treatment with DOTA-GGC-NP precludes migration and reorganization of the cells, stopping the tube formation progress (Fig. 6b) ; furthermore, cells appear in close proximity and firmly adhere to the matrix, but polygonal structures were not formed. It has been reported that gold nanoparticles have antiangiogenic properties because they selectively interact with cell mitogens and mediators of angiogenesis, particularly blocking the VEGF165/VEGFR2 interaction [22] . The observed cell adhesion is likely to be triggered and maintained by the signaling transduction mediated by cell adhesion molecules such as integrins and its transactivation via the other growth factors present in the FBS such as EGF, which is not affected by NPs.
Exposure of cells to gold nanoparticles conjugated with the NLS-RGD peptide significantly reduced cell adhesion properties and abolished the ability of endothelial cells to form tubes even in the presence of proangiogenic stimulation (Fig. 6c) . Cells exposed to DOTA-GGC-NP-NLS-RGD acquired a rounded shape, and some of them made contact, forming groups of maximum four cells (Fig. 6c) . This response is certainly due to the known blocking that RGD exerts on a(v)b(3) integrin [7] . It is well known that this integrin plays key roles in cell-cell and cell-ECM interaction, this explains the lack of cell adhesion and the reduced intercellular contact. Some authors have validated that organelle-specific damage can be amplified by targeting molecules to the nucleus, and Kang et al. [23] have demonstrated that the DNA damage, cell division arrest and apoptosis produced by NPs could be increased by modifying NPs with the NLS sequence.
The conjugation to DOTA-GGC-NP of the RNA aptamer directed against VEGF slightly increased the antiangiogenic effect produced by the nanoparticles (Fig. 6e) . Cells treated with DOTA-GGC-NP-Aptamer remained firmly attached to the matrix and approximately one-third of the population sprouted and maintained their ability to associate and form branched clusters without achieving complete formation of polygonal structures (Fig. 6e) . The maintenance of cell adhesion and chemotaxis properties are due to the angiogenic signaling mediated by other growth factors, cytokines, chemokines and hormones present in the FBS.
The DOTA-GGC-NP-NLS-RGD-Aptamer nanosystem here reported, inhibits tube formation (Fig. 6f) . In these culture conditions, the loss of cell adhesion, migration and protrusion was observed and very few cells could maintain contact with others.
Semi-quantitative measurement of the angiogenic potential (AP) of the tested compounds, in terms of their kinetics to bring about EA.hy926 cell line remodeling into tube structures, evidenced that a greater AP was reached by the DOTA-GGC-NP-NLS-RGD-Aptamer nanosystem with a score of 0.33 ± 0.05, which is significantly lower than that of the 2.04 ± 0.19 score obtained for the positive control, in which the maximum reorganization was observed, obtaining the formation of a complex mesh. DOTA-GGC-NP and DOTA-GGC-NP-Aptamer reduced the AP score to 0.99 ± 0.10 and 0.78 ± 0.06, respectively, while in DOTA-GGC-NP-NLS-RGD, the AP was 0.54 ± 0.08. In this study, the synergic antiangiogenic properties of a nanosystem able to simultaneously target VEGF and integrins with a remarkable ability to inhibit signals through VEGFR and interfering with its transactivation via integrins, was demonstrated.
Internalization assay
As shown in Table 1 Lu-NP nonspecific accumulation in C6 glioblastoma cells is related to the NP passive uptake mechanism [24] . However, with the conjugation to NPs of NLS-RGD and aptamer, the specific tumor cell internalization was significantly higher (Table 1) . 177 Lu-NP-NLS-RGD-Aptamer internalized in cell nuclei also demonstrated a specific nuclear entry (Fig. 7) .
Since the C6 cell line overexpress a(v)b(3) integrin, the uptake and internalization of NLS-RGD molecules was that expected. This is in agreement with previous works in which the affinity of RGD to the a(v)b(3) integrin and NLS internalization properties have been reported [8] .
At the first glance, it is difficult to understand the aptamer uptake and internalization effect, because the aptamer molecule is negatively-charged and typically, the cell membrane has negative charge characteristics. Different endocytic pathways taken by aptamer-NPs have been reported [25] . Aptamer-NPs colloidal systems, however, exhibit good cell uptake properties. Furthermore, the cell uptake and internalization of NP-aptamer has been reported to be higher than that of NPs [26] . The internalization mechanisms and intracellular trafficking of nanoparticles require further studies, especially regarding the difference between targeted and non-targeted nanoparticles.
Fluorescence microscopy images
As shown in Fig. 7 , 177 Lu-NP-NLS-RGD-Aptamer emits the highest fluorescence, which indicates a higher NP internalization in C6 cells due to the NLS-RGD and aptamer interactions with the membrane cell. This agrees with the result of the uptake and internalization described above (Table 1) . Hoechst dye inside the nuclei was visualized with an excitation filter of 330-385 nm and an emission filter of 420 nm, and the NPs were detected by using an excitation filter of 530-550 nm and an emission filter of 590 nm.
The fluorescence present in the colloidal systems 177 Lu-NP-NLS-RGD, 177 Lu-NP-Aptamer and 177 Lu-NP-NLS- RGD-Aptamer, once internalized in C6 cell, can be attributed to the aggregation-induced emission phenomenon [27] . 177 Lu-NP-conjugates may undergo an aggregation phenomenon that modifies their physical properties and enhances the fluorescence present in NPs colloidal systems.
177 Lu-NP-NLS-RGD-Aptamer showed larger mean intensity that the rest of the treatments (Fig. 7) , which is correlated with a strong fluorescence phenomenon present inside the cells.
Conclusions
TEM, DLS and spectroscopy techniques demonstrated that NPs could be successfully conjugated to NLS-RGD and HSpentyl-pegaptanib (aptamer) through interactions with the thiol groups of cysteine.
177
Lu-NP-NLS-RGD-Aptamer, with a radiochemical purity[98%, is highly stable in human serum and shows specific recognition for a(v)b(3) integrin and VEGF (in vitro inhibition of vascular-tube formation). The cancer-specific 177 Lu-Au-nanoradiopharmaceutical shows suitable properties as a specific antiangiogenic agent by targeting both the VEGF pathway and a(v)b(3) integrin. The results obtained in this study warrant further preclinical studies to determine the in vivo specificity and the radiotherapeutic and antiangogenic properties of the 177 Lu-NP-NLS-RGD-Aptamer radiopharmaceutical.
